CTDP1

CTD phosphatase subunit 1, the group of CTD family phosphatases

Basic information

Region (hg38): 18:79679803-79754503

Links

ENSG00000060069NCBI:9150OMIM:604927HGNC:2498Uniprot:Q9Y5B0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • congenital cataracts-facial dysmorphism-neuropathy syndrome (Definitive), mode of inheritance: AR
  • congenital cataracts-facial dysmorphism-neuropathy syndrome (Supportive), mode of inheritance: AR
  • congenital cataracts-facial dysmorphism-neuropathy syndrome (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Congenital cataracts, facial dysmorphism, and neuropathyAREndocrine; Pharmacogenomic; RenalIn Hypogonadotropic hypogonadism, surveillance in adolescence related to sexual maturation is indicated, as is monitoring of bone mineral density in order to allow early detection and treatment of disease; In the instance of anesthesia, monitoring is indicated, (eg, for severe complications such as stridor, pulmonary edema, malignant hyperthermia, and seizures); Individuals may suffer severe rhabdomyolysis related to viral infections, and awareness may allow rapid managementCardiovascular; Endocrine; Musculoskeletal; Neurologic; Ophthalmologic; Renal10439962; 10360766; 10442556; 14517542; 16194727; 16939648; 20301787; 21824574

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CTDP1 gene.

  • Congenital cataracts-facial dysmorphism-neuropathy syndrome (1 variants)
  • Charcot-Marie-Tooth disease (1 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTDP1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
125
clinvar
17
clinvar
144
missense
181
clinvar
22
clinvar
9
clinvar
212
nonsense
3
clinvar
3
start loss
0
frameshift
3
clinvar
3
inframe indel
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
6
14
6
26
non coding
1
clinvar
1
clinvar
82
clinvar
39
clinvar
123
Total 1 0 192 229 66

Variants in CTDP1

This is a list of pathogenic ClinVar variants found in the CTDP1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-79679844-G-T Benign (Jun 29, 2018)1226092
18-79679899-G-C Likely benign (Nov 02, 2020)1707384
18-79679914-C-T Likely benign (May 17, 2019)1209235
18-79679943-C-T CTDP1-related disorder Likely benign (Oct 29, 2021)3057683
18-79679953-G-A Likely benign (Jan 15, 2024)1896566
18-79679953-G-T Uncertain significance (Mar 18, 2022)2103747
18-79679961-C-A Benign (Jan 22, 2024)1567843
18-79679961-C-T Uncertain significance (Jul 30, 2022)2051125
18-79679974-T-G Likely benign (Sep 05, 2023)2868462
18-79679975-C-T Uncertain significance (Oct 13, 2022)1504142
18-79679981-G-C Uncertain significance (Feb 09, 2022)2683461
18-79679989-C-T Likely benign (May 03, 2022)2133093
18-79679990-C-T not specified Uncertain significance (Feb 13, 2024)1521381
18-79679992-G-A Likely benign (Apr 24, 2023)2808429
18-79679993-A-C Uncertain significance (Mar 04, 2022)2102006
18-79679995-G-A Likely benign (Mar 01, 2023)2057363
18-79679998-G-A Likely benign (Dec 22, 2023)2087296
18-79680005-G-A Uncertain significance (Jun 05, 2024)2081160
18-79680005-G-T Uncertain significance (Feb 09, 2022)2095390
18-79680007-C-T Likely benign (Sep 08, 2023)719208
18-79680018-G-T not specified Uncertain significance (Jul 25, 2023)1525483
18-79680020-C-T Uncertain significance (Jul 29, 2022)2003770
18-79680024-G-A not specified Uncertain significance (Aug 30, 2023)1373323
18-79680025-G-C Likely benign (Jan 18, 2024)732570
18-79680028-C-G Likely benign (Feb 25, 2022)2103722

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CTDP1protein_codingprotein_codingENST00000299543 1374710
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0006000.9991257290191257480.0000756
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9965015680.8820.00004036141
Missense in Polyphen171249.170.686262750
Synonymous-1.502932621.120.00002201950
Loss of Function3.861339.00.3330.00000237432

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008670.0000867
Ashkenazi Jewish0.00009920.0000992
East Asian0.000.00
Finnish0.0001850.000185
European (Non-Finnish)0.00008070.0000791
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Processively dephosphorylates 'Ser-2' and 'Ser-5' of the heptad repeats YSPTSPS in the C-terminal domain of the largest RNA polymerase II subunit. This promotes the activity of RNA polymerase II. Plays a role in the exit from mitosis by dephosphorylating crucial mitotic substrates (USP44, CDC20 and WEE1) that are required for M-phase-promoting factor (MPF)/CDK1 inactivation. {ECO:0000269|PubMed:22692537}.;
Disease
DISEASE: Congenital cataracts, facial dysmorphism, and neuropathy (CCFDN) [MIM:604168]: An autosomal recessive developmental disorder characterized by a complex clinical phenotype with seemingly unrelated features involving multiple organs and systems. Developmental abnormalities include congenital cataracts and microcorneae, hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, facial dysmorphism and hypogonadism. Central nervous system involvement, with cerebral and spinal cord atrophy, may be the result of disrupted development with superimposed degenerative changes. Affected individuals are prone to severe rhabdomyolysis after viral infections and to serious complications related to general anesthesia (such as pulmonary edema and epileptic seizures). {ECO:0000269|PubMed:14517542}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Disease;Formation of the HIV-1 Early Elongation Complex;Gene expression (Transcription);Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Abortive elongation of HIV-1 transcript in the absence of Tat;HIV Transcription Elongation;HIV elongation arrest and recovery;Formation of HIV elongation complex in the absence of HIV Tat;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Tat-mediated HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex ;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Transcription Elongation;TP53 Regulates Transcription of DNA Repair Genes;Transcriptional Regulation by TP53;Formation of the Early Elongation Complex (Consensus)

Recessive Scores

pRec
0.230

Intolerance Scores

loftool
0.251
rvis_EVS
-0.84
rvis_percentile_EVS
11.48

Haploinsufficiency Scores

pHI
0.118
hipred
Y
hipred_score
0.749
ghis
0.543

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.955

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ctdp1
Phenotype

Zebrafish Information Network

Gene name
ctdp1
Affected structure
head
Phenotype tag
abnormal
Phenotype quality
pointed

Gene ontology

Biological process
transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;protein dephosphorylation;exit from mitosis;positive regulation by host of viral transcription;cell division;negative regulation of cell growth involved in cardiac muscle cell development;dephosphorylation of RNA polymerase II C-terminal domain
Cellular component
spindle pole;nucleus;nucleoplasm;cytoplasm;centrosome;spindle;midbody;protein-containing complex;intracellular membrane-bounded organelle;spindle midzone
Molecular function
TFIIF-class transcription factor complex binding;phosphoprotein phosphatase activity;protein binding;RNA polymerase II CTD heptapeptide repeat phosphatase activity;Tat protein binding